Thermo Fisher Scientific SARS-CoV-2 Nucleocapsid Chimeric Recombinant Human Monoclonal Antibody (N32HC)

Applications

ELISA

• Tested Dilution: 0.01–0.1 µg/mL

Functional Assay

• Tested Dilution: Assay-dependent

Product Specifications

Product Specific Information

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus that caused COVID-19.
Nucleocapsid Protein is the most abundant structural protein of the coronavirus and is associated with nucleic acid.
SARS-CoV-2 Nucleocapsid Antibody (N32HC), Human Chimeric, is produced from cell culture in vitro under conditions free from animal-derived components.

Target Information

SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid and is the most abundant protein of coronavirus.
Due to its strong immunogenicity, the Nucleocapsid Protein has potential diagnostic value for SARS-CoV-2.
The N protein is an abundant RNA-binding protein critical for viral genome packaging. It contains three dynamic disordered regions with transiently helical binding motifs.
The two folded domains interact minimally, making the full-length N protein a flexible and multivalent RNA-binding protein.
SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.